Cefepime (CEFEPIME HYDROCHLORIDE AND DEXTROSE)
$27.5M in CY2024 Part D spend150K claims · 51K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Cefepime used for?
Cefepime is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Cefepime?
Yes. 10 ANDAs filed at FDA, 5 generic manufacturers currently shipping.
How much does my plan pay for Cefepime?
Across 329 Part D plans, Cefepime averages $3.73/unit (NADAC). Lowest available: $3.73/unit. Highest in distribution: $3.73/unit.
Is Cefepime on the FDA shortage list?
Cefepime has been discontinued by its manufacturer(s).
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (8 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.